SNDX

Syndax Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 1/10
  • Value↓ 0/10
Syndax Pharmaceuticals sales and earnings growth
SNDX Growth
Low
  • Revenue Y/Y↑ 627.84%
  • EPS Y/Y↑ 11.56%
  • FCF Y/Y↓ -17.56%
Syndax Pharmaceuticals gross and profit margin trends
SNDX Profitability
Neutral
  • Gross margin ↑ 96.00%
  • EPS margin↓ -165.60%
  • ROIC 5Y↓ -61.19%
Syndax Pharmaceuticals net debt vs free cash flow
SNDX Risk
Poor
  • Debt / Equity↑ 5.3
  • Debt / FCF↓ 0.7
  • Interest coverage↓ -7.4

Syndax Pharmaceuticals stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Biotechnology stocks ↗